Disruption of immune regulation by microbial pathogens and resulting chronic inflammation

Journal of Cellular Physiology

Volumn 228, Issue 7, 2013, Pages 1413-1422

  Barth, Kenneth ^a   Remick, Daniel G ^a   Genco, Caroline A ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ANTIGEN RECOGNITION; APOPTOSIS; BACTERIAL VIRULENCE; CELL DISRUPTION; CHRONIC INFLAMMATION; GENE DISRUPTION; IMMUNE EVASION; IMMUNOREGULATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; REVIEW;

BACTERIAL INFECTIONS; BACTEROIDACEAE INFECTIONS; CHRONIC DISEASE; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATION; MODELS, IMMUNOLOGICAL; MYCOBACTERIUM TUBERCULOSIS; PORPHYROMONAS GINGIVALIS; SIGNAL TRANSDUCTION; TUBERCULOSIS, PULMONARY;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM TUBERCULOSIS; PORPHYROMONAS GINGIVALIS;

EID: 84875551473     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24299     Document Type: Review

References (88)

1. Ahmad S. 2011. Pathogenesis, immunology, and diagnosis of latent Mycobacterium tuberculosis infection. Clin Dev Immunol 2011: 814943.
2. Baena A, Porcelli SA. 2009. Evasion and subversion of antigen presentation by Mycobacterium tuberculosis . Tissue Antigens 74: 189-204.
3. Behar SM, Divangahi M, Remold HG. 2010. Evasion of innate immunity by Mycobacterium tuberculosis: Is death an exit strategy? Nat Rev Microbiol 8: 668-674.
4. Belanger M, Rodrigues PH, Dunn WA, Jr., Progulske-Fox A. 2006. Autophagy: A highway for Porphyromonas gingivalis in endothelial cells. Autophagy 2: 165-170.
5. Bryk R, Griffin P, Nathan C. 2000. Peroxynitrite reductase activity of bacterial peroxiredoxins. Nature 407: 211-215.
6. Bustamante J, Aksu G, Vogt G, de Beaucoudrey L, Genel F, Chapgier A, Filipe-Santos O, Feinberg J, Emile JF, Kutukculer N, Casanova JL. 2007. BCG-osis and tuberculosis in a child with chronic granulomatous disease. J Allergy Clin Immunol 120: 32-38.
7. Chan J, Fan XD, Hunter SW, Brennan PJ, Bloom BR. 1991. Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages. Infect Immun 59: 1755-1761.
8. Chan J, Fujiwara T, Brennan P, McNeil M, Turco SJ, Sibille JC, Snapper M, Aisen P, Bloom BR. 1989. Microbial glycolipids: Possible virulence factors that scavenge oxygen radicals. Proc Natl Acad Sci USA 86: 2453-2457.
9. Chen M, Gan H, Remold HG. 2006. A mechanism of virulence: Virulent Mycobacterium tuberculosis strain H37Rv, but not attenuated H37Ra, causes significant mitochondrial inner membrane disruption in macrophages leading to necrosis. J Immunol 176: 3707-3716.
10. Clemens DL, Horwitz MA. 1996. The Mycobacterium tuberculosis phagosome interacts with early endosomes and is accessible to exogenously administered transferrin. J Exp Med 184: 1349-1355.
11. Coats SR, Jones JW, Do CT, Braham PH, Bainbridge BW, To TT, Goodlett DR, Ernst RK, Darveau RP. 2009. Human Toll-like receptor 4 responses to P. gingivalis are regulated by lipid A 1- and 4′-phosphatase activities. Cell Microbiol 11: 1587-1599.
12. Condorelli F, Scalia G, Cali G, Rossetti B, Nicoletti G, Lo Bue AM. 1998. Isolation of Porphyromonas gingivalis and detection of immunoglobulin A specific to fimbrial antigen in gingival crevicular fluid. J Clin Microbiol 36: 2322-2325.
13. -/-) mice. Infect Immun 68: 1231-1234.
14. Danser MM, Timmerman MF, van Winkelhoff AJ, van der Velden U. 1996. The effect of periodontal treatment on periodontal bacteria on the oral mucous membranes. J Periodontol 67: 478-485.
15. Diacovich L, Gorvel JP. 2010. Bacterial manipulation of innate immunity to promote infection. Nat Rev Microbiol 8: 117-128.
16. Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nunez G, Schnurr M, Espevik T, Lien E, Fitzgerald KA, Rock KL, Moore KJ, Wright SD, Hornung V, Latz E. 2010. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464: 1357-1361.
17. Ehrt S, Schnappinger D. 2009. Mycobacterial survival strategies in the phagosome: Defence against host stresses. Cell Microbiol 11: 1170-1178.
18. Ehrt S, Shiloh MU, Ruan J, Choi M, Gunzburg S, Nathan C, Xie Q, Riley LW. 1997. A novel antioxidant gene from Mycobacterium tuberculosis . J Exp Med 186: 1885-1896.
19. Fang FC. 2004. Antimicrobial reactive oxygen and nitrogen species: Concepts and controversies. Nat Rev Microbiol 2: 820-832.
20. Flynn JL, Chan J. 2001. Immunology of tuberculosis. Ann Rev Immunol 19: 93-129.
21. Flynn JL, Chan J. 2003. Immune evasion by Mycobacterium tuberculosis: Living with the enemy. Curr Opin Immunol 15: 450-455.
22. Flynn JL, Scanga CA, Tanaka KE, Chan J. 1998. Effects of aminoguanidine on latent murine tuberculosis. J Immunol 160: 1796-1803.
23. Fratti RA, Backer JM, Gruenberg J, Corvera S, Deretic V. 2001. Role of phosphatidylinositol 3-kinase and Rab5 effectors in phagosomal biogenesis and mycobacterial phagosome maturation arrest. J Cell Biol 154: 631-644.
24. Gamonal J, Acevedo A, Bascones A, Jorge O, Silva A. 2000. Levels of interleukin-1 beta, -8, and -10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal treatment. J Periodontol 71: 1535-1545.
25. Geijtenbeek TB, Van Vliet SJ, Koppel EA, Sanchez-Hernandez M, Vandenbroucke-Grauls CM, Appelmelk B, Van Kooyk Y. 2003. Mycobacteria target DC-SIGN to suppress dendritic cell function. J Exp Med 197: 7-17.
26. Gibson FC, III., Hong C, Chou HH, Yumoto H, Chen J, Lien E, Wong J, Genco CA. 2004. Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation 109: 2801-2806.
27. Gibson FC III, Yumoto H, Takahashi Y, Chou HH, Genco CA. 2006. Innate immune signaling and Porphyromonas gingivalis-accelerated atherosclerosis. J Dental Res 85: 106-121.
28. Gregory RL, Kim DE, Kindle JC, Hobbs LC, Lloyd DR. 1992. Immunoglobulin-degrading enzymes in localized juvenile periodontitis. J Periodontal Res 27: 176-183.
29. Gupta A, Kaul A, Tsolaki AG, Kishore U, Bhakta S. 2012. Mycobacterium tuberculosis: Immune evasion, latency, and reactivation. Immunobiology 217: 363-374.
30. Hajishengallis G, Shakhatreh MA, Wang M, Liang S. 2007. Complement receptor 3 blockade promotes IL-12-mediated clearance of Porphyromonas gingivalis and negates its virulence in vivo. J Immunol 179: 2359-2367.
31. Hajishengallis G, Wang M, Harokopakis E, Triantafilou M, Triantafilou K. 2006. Porphyromonas gingivalis fimbriae proactively modulate beta2 integrin adhesive activity and promote binding to and internalization by macrophages. Infect Immun 74: 5658-5666.
32. Hajishengallis G, Wang M, Liang S, Triantafilou M, Triantafilou K. 2008. Pathogen induction of CXCR4/TLR2 cross-talk impairs host defense function. Proc Natl Acad Sci USA 105: 13532-13537.
33. Hanekom WA, Mendillo M, Manca C, Haslett PA, Siddiqui MR, Barry C, III., Kaplan G. 2003. Mycobacterium tuberculosis inhibits maturation of human monocyte-derived dendritic cells in vitro. J Infect Dis 188: 257-266.
34. Harding CV, Boom WH. 2010. Regulation of antigen presentation by Mycobacterium tuberculosis: A role for Toll-like receptors. Nat Rev Microbiol 8: 296-307.
35. Hinchey J, Lee S, Jeon BY, Basaraba RJ, Venkataswamy MM, Chen B, Chan J, Braunstein M, Orme IM, Derrick SC, Morris SL, Jacobs WR, Jr., Porcelli SA. 2007. Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis . J Clin Invest 117: 2279-2288.
36. Imamura T. 2003. The role of gingipains in the pathogenesis of periodontal disease. J Periodontol 74: 111-118.
37. Indrigo J, Hunter RL, Jr., Actor JK. 2003. Cord factor trehalose 6, 6′-dimycolate (TDM) mediates trafficking events during mycobacterial infection of murine macrophages. Microbiology 149: 2049-2059.
38. Jayachandran R, Sundaramurthy V, Combaluzier B, Mueller P, Korf H, Huygen K, Miyazaki T, Albrecht I, Massner J, Pieters J. 2007. Survival of mycobacteria in macrophages is mediated by coronin 1-dependent activation of calcineurin. Cell 130: 37-50.
39. Jung YJ, LaCourse R, Ryan L, North RJ. 2002. Virulent but not avirulent Mycobacterium tuberculosis can evade the growth inhibitory action of a T helper 1-dependent, nitric oxide Synthase 2-independent defense in mice. J Exp Med 196: 991-998.
40. Kan-Sutton C, Jagannath C, Hunter RL, Jr. 2009. Trehalose 6, 6′-dimycolate on the surface of Mycobacterium tuberculosis modulates surface marker expression for antigen presentation and costimulation in murine macrophages. Microbes Infection/Institut Pasteur 11: 40-48.
41. Kang PB, Azad AK, Torrelles JB, Kaufman TM, Beharka A, Tibesar E, DesJardin LE, Schlesinger LS. 2005. The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. J Exp Med 202: 987-999.
42. Korbel DS, Schneider BE, Schaible UE. 2008. Innate immunity in tuberculosis: Myths and truth. Microb Infect/Institut Pasteur 10: 995-1004.
43. Lee WL, Gold B, Darby C, Brot N, Jiang X, de Carvalho LP, Wellner D, St John G, Jacobs WR, Jr., Nathan C. 2009. Mycobacterium tuberculosis expresses methionine sulphoxide reductases A and B that protect from killing by nitrite and hypochlorite. Mol Microbiol 71: 583-593.
44. Li L, Messas E, Batista EL, Jr., Levine RA, Amar S. 2002. Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation 105: 861-867.
45. Li L, Michel R, Cohen J, Decarlo A, Kozarov E. 2008. Intracellular survival and vascular cell-to-cell transmission of Porphyromonas gingivalis . BMC Microbiol 8: 26.
46. Liang S, Krauss JL, Domon H, McIntosh ML, Hosur KB, Qu H, Li F, Tzekou A, Lambris JD, Hajishengallis G. 2011. The C5a receptor impairs IL-12-dependent clearance of Porphyromonas gingivalis and is required for induction of periodontal bone loss. J Immunol 186: 869-877.
47. Lockhart PB, Bolger AF, Papapanou PN, Osinbowale O, Trevisan M, Levison ME, Taubert KA, Newburger JW, Gornik HL, Gewitz MH, Wilson WR, Smith SC, Jr., Baddour LM. 2012. Periodontal disease and atherosclerotic vascular disease: Does the evidence support an independent association? A scientific statement from the American Heart Association. Circulation 125: 2520-2544.
48. Lowell CA. 2006. Rewiring phagocytic signal transduction. Immunity 24: 243-245.
49. MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, Nathan CF. 1997. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci USA 94: 5243-5248.
50. Madrigal AG, Barth K, Papadopoulos G, Genco CA. 2012. Pathogen-mediated proteolysis of the cell death regulator RIPK1 and the host defense modulator RIPK2 in human aortic endothelial cells. PLoS Pathog 8: e1002723.
51. Master SS, Rampini SK, Davis AS, Keller C, Ehlers S, Springer B, Timmins GS, Sander P, Deretic V. 2008. Mycobacterium tuberculosis prevents inflammasome activation. Cell Host Microb 3: 224-232.
52. Meylan E, Tschopp J. 2005. The RIP kinases: Crucial integrators of cellular stress. Trends Biochem Sci 30: 151-159.
53. Miller BH, Fratti RA, Poschet JF, Timmins GS, Master SS, Burgos M, Marletta MA, Deretic V. 2004. Mycobacteria inhibit nitric oxide synthase recruitment to phagosomes during macrophage infection. Infect Immun 72: 2872-2878.
54. Miller SI, Ernst RK, Bader MW. 2005. LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol 3: 36-46.
55. Moskovitz J. 2005. Methionine sulfoxide reductases: Ubiquitous enzymes involved in antioxidant defense, protein regulation, and prevention of aging-associated diseases. Biochim Biophys Acta 1703: 213-219.
56. Nigou J, Zelle-Rieser C, Gilleron M, Thurnher M, Puzo G. 2001. Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: Evidence for a negative signal delivered through the mannose receptor. J Immunol 166: 7477-7485.
57. Noss EH, Pai RK, Sellati TJ, Radolf JD, Belisle J, Golenbock DT, Boom WH, Harding CV. 2001. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis . J Immunol 167: 910-918.
58. Ogawa T, Kusumoto Y, Hamada S, McGhee JR, Kiyono H. 1990. Bacteroides P. gingivalis-specific serum IgG and IgA subclass antibodies in periodontal diseases. Clin Exp Immunol 82: 318-325.
59. Pai RK, Convery M, Hamilton TA, Boom WH, Harding CV. 2003. Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: A potential mechanism for immune evasion. J Immunol 171: 175-184.
60. Paster BJ, Olsen I, Aas JA, Dewhirst FE. 2006. The breadth of bacterial diversity in the human periodontal pocket and other oral sites. Periodontology 42: 80-87.
61. Philips JA. 2008. Mycobacterial manipulation of vacuolar sorting. Cell Microbiol 10: 2408-2415.
62. Popadiak K, Potempa J, Riesbeck K, Blom AM. 2007. Biphasic effect of gingipains from Porphyromonas gingivalis on the human complement system. J Immunol 178: 7242-7250.
63. Potempa M, Potempa J, Okroj M, Popadiak K, Eick S, Nguyen KA, Riesbeck K, Blom AM. 2008. Binding of complement inhibitor C4b-binding protein contributes to serum resistance of Porphyromonas gingivalis . J Immunol 181: 5537-5544.
64. Raghuvanshi S, Sharma P, Singh S, Van Kaer L, Das G. 2010. Mycobacterium tuberculosis evades host immunity by recruiting mesenchymal stem cells. Proc Natl Acad Sci USA 107: 21653-21658.
65. Rogerson BJ, Jung YJ, LaCourse R, Ryan L, Enright N, North RJ. 2006. Expression levels of Mycobacterium tuberculosis antigen-encoding genes versus production levels of antigen-specific T cells during stationary level lung infection in mice. Immunology 118: 195-201.
66. Ruan J, St John G, Ehrt S, Riley L, Nathan C. 1999. noxR3, a novel gene from Mycobacterium tuberculosis, protects Salmonella typhimurium from nitrosative and oxidative stress. Infect Immun 67: 3276-3283.
67. Russell DG. 2001. Mycobacterium tuberculosis: Here today, and here tomorrow. Nat Rev Mol Cell Biol 2: 569-577.
68. Salvi GE, Beck JD, Offenbacher S. 1998. PGE2, IL-1 beta, and TNF-alpha responses in diabetics as modifiers of periodontal disease expression. Ann Periodontol 3: 40-50.
69. Schenkein HA, Genco RJ. 1977. Gingival fluid and serum in periodontal diseases. I. Quantitative study of immunoglobulins, complement components, and other plasma proteins. J Periodontol 48: 772-777.
70. Senaratne RH, De Silva AD, Williams SJ, Mougous JD, Reader JR, Zhang T, Chan S, Sidders B, Lee DH, Chan J, Bertozzi CR, Riley LW. 2006. 5′-Adenosinephosphosulphate reductase (CysH) protects Mycobacterium tuberculosis against free radicals during chronic infection phase in mice. Mol Microbiol 59: 1744-1753.
71. Sendide K, Reiner NE, Lee JS, Bourgoin S, Talal A, Hmama Z. 2005. Cross-talk between CD14 and complement receptor 3 promotes phagocytosis of mycobacteria: Regulation by phosphatidylinositol 3-kinase and cytohesin-1. J Immunol 174: 4210-4219.
72. Slaney JM, Gallagher A, Aduse-Opoku J, Pell K, Curtis MA. 2006. Mechanisms of resistance of Porphyromonas gingivalis to killing by serum complement. Infect Immun 74: 5352-5361.
73. Socransky SS, Haffajee AD, Ximenez-Fyvie LA, Feres M, Mager D. 1999/2000. Ecological considerations in the treatment of Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis periodontal infections. Periodontology 20: 341-362.
74. Sturgill-Koszycki S, Schlesinger PH, Chakraborty P, Haddix PL, Collins HL, Fok AK, Allen RD, Gluck SL, Heuser J, Russell DG. 1994. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science 263: 678-681.
75. Sugawara S, Nemoto E, Tada H, Miyake K, Imamura T, Takada H. 2000. Proteolysis of human monocyte CD14 by cysteine proteinases (gingipains) from Porphyromonas gingivalis leading to lipopolysaccharide hyporesponsiveness. J Immunol 165: 411-418.
76. Sun J, Wang X, Lau A, Liao TY, Bucci C, Hmama Z. 2010. Mycobacterial nucleoside diphosphate kinase blocks phagosome maturation in murine RAW 264.7 macrophages. PLoS ONE 5: e8769.
77. Tischler AD, McKinney JD. 2010. Contrasting persistence strategies in Salmonella and Mycobacterium . Curr Opin Microbiol 13: 93-99.
78. Via LE, Fratti RA, McFalone M, Pagan-Ramos E, Deretic D, Deretic V. 1998. Effects of cytokines on mycobacterial phagosome maturation. J Cell Sci 111: 897-905.
79. Wang M, Krauss JL, Domon H, Hosur KB, Liang S, Magotti P, Triantafilou M, Triantafilou K, Lambris JD, Hajishengallis G. 2010. Microbial hijacking of complement-toll-like receptor crosstalk. Sci Signal 3: ra11.
80. Wang M, Shakhatreh MA, James D, Liang S, Nishiyama S, Yoshimura F, Demuth DR, Hajishengallis G. 2007. Fimbrial proteins of porphyromonas gingivalis mediate in vivo virulence and exploit TLR2 and complement receptor 3 to persist in macrophages. J Immunol 179: 2349-2358.
81. Welin A, Winberg ME, Abdalla H, Sarndahl E, Rasmusson B, Stendahl O, Lerm M. 2008. Incorporation of Mycobacterium tuberculosis lipoarabinomannan into macrophage membrane rafts is a prerequisite for the phagosomal maturation block. Infect Immun 76: 2882-2887.
82. World Health Organization. 2012. Global Tuberculosis Report. http://www.who.int/tb/publications/global_report/en/. Geneva, Switzerland.
83. Yamatake K, Maeda M, Kadowaki T, Takii R, Tsukuba T, Ueno T, Kominami E, Yokota S, Yamamoto K. 2007. Role for gingipains in Porphyromonas gingivalis traffic to phagolysosomes and survival in human aortic endothelial cells. Infect Immun 75: 2090-2100.
84. Yang HW, Huang YF, Chou MY. 2004. Occurrence of Porphyromonas gingivalis and Tannerella forsythensis in periodontally diseased and healthy subjects. J Periodontol 75: 1077-1083.
85. Yu K, Mitchell C, Xing Y, Magliozzo RS, Bloom BR, Chan J. 1999. Toxicity of nitrogen oxides and related oxidants on mycobacteria: M. tuberculosis is resistant to peroxynitrite anion. Int J Tuberc Lung Dis 79: 191-198.
86. Yun LW, Decarlo AA, Hunter N. 2007. Blockade of protease-activated receptors on T cells correlates with altered proteolysis of CD27 by gingipains of Porphyromonas gingivalis . Clin Exp Immunol 150: 217-229.
87. Zahrt TC, Deretic V. 2002. Reactive nitrogen and oxygen intermediates and bacterial defenses: Unusual adaptations in Mycobacterium tuberculosis . Antioxid Redox Signal 4: 141-159.
88. Zeituni AE, Jotwani R, Carrion J, Cutler CW. 2009. Targeting of DC-SIGN on human dendritic cells by minor fimbriated Porphyromonas gingivalis strains elicits a distinct effector T cell response. J Immunol 183: 5694-5704.